Spiking Pandemic Potential: Structural and Immunological Aspects of SARS-CoV-2
- Ying Ting Wang,
- Sara Landeras-Bueno,
- Li En Hsieh,
- Yutaka Terada,
- Kenneth Kim,
- LA JOLLA INSTITUTE FOR IMMUNOLOGY,
- University of California at San Diego,
- Tennessee Department of Agriculture,
- ,
- ,
Open access
Sustainable Development Goals
- SDG 3 Good Health and Well
Abstract
SARS-Coronavirus-2 (SARS-CoV-2) causes Coronavirus disease 2019 (COVID-19), an infectious respiratory disease causing thousands of deaths and overwhelming public health systems. The international spread of SARS-CoV-2 is associated with the ease of global travel, and societal dynamics, immunologic naiveté of the host population, and muted innate immune responses. Based on these factors and the expanding geographic scale of the disease, the World Health Organization (WHO) declared the COVID-19 outbreak a pandemic–the first caused by a coronavirus. In this review, we summarize the current epidemiological status of COVID-19 and consider the virological and immunological lessons, animal models, and tools developed in response to prior SARS-CoV and MERS-CoV outbreaks that can serve as resources for development of SARS-CoV-2 therapeutics and vaccines. In particular, we discuss structural insights into the SARS-CoV-2 spike protein, a major determinant of transmissibility, and discuss key molecular aspects that will aid in understanding and fighting this new global threat.
Publication Information
Output type
Original language
English (US)Pages from-to (Number of pages)
Pages 605-618 (14 pages)Journal (Volume, Issue Number)
Trends in Microbiology (Volume 28, Issue 8)Publication milestones
- Published - 08/2020
Publication status
ISSN
0966-842XPublication IDs
- Scopus: 85085923286
- PubMed: 32507543
